Large animal model for retroperitoneal lymphatic and lung metastasis

por HUANG, YONG-WEN, GUAN, MING-FEI, LIU, JI-HONG, LAN, CHUN-YAN, WAN, TING, HUANG, XIN
Publicado 2013

Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits

por Huang, Yong-Wen, Zhou, Yun, Lan, Chun-Yan, Wang, Yin, Feng, Yan-Ling, Luo, Rong-Zhen, Liu, Ji-Hong
Publicado 2015

iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling

por Xiong, Ying, Sun, Fei, Dong, Peixin, Watari, Hidemichi, Yue, Junming, Yu, Min-fei, Lan, Chun-yan, Wang, Yin, Ma, Ze-biao
Publicado 2017

The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages

por Pan, Baoyue, Wan, Ting, Zhou, Yun, Huang, Shuting, Yuan, Linjing, Jiang, Yinan, Zheng, Xiaojing, Liu, Pingping, Xiang, Huiling, Ju, Mingxiu, Luo, Rongzhen, Jia, Weihua, Lan, ChunYan, Li, Jundong, Zheng, Min
Publicado 2023

Anlotinib combined with TQB2450 in patients with platinum-resistant or -refractory ovarian cancer: A multi-center, single-arm, phase 1b trial

por Lan, Chun-Yan, Zhao, Jing, Yang, Fan, Xiong, Ying, Li, Rong, Huang, Yu, Wang, Jing, Liu, Chang, Bi, Xue-Han, Jin, Hai-Hong, Meng, Jin, Zhao, Wei-Hong, Zhang, Li, Wang, Ya-Fei, Zheng, Min, Huang, Xin
Publicado 2022